These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6501130)

  • 1. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM
    J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM; Lamothe F
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of standardization of in-vitro susceptibility testing of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
    Brown EM
    J Antimicrob Chemother; 1991 Jul; 28(1):147-9. PubMed ID: 1769936
    [No Abstract]   [Full Text] [Related]  

  • 5. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
    Downes J; Andrew JH
    Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
    Traub WH
    Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
    García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
    J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False amoxicillin/clavulanic acid susceptibility in Bacteroides fragilis using gradient strip tests.
    Rentenaar RJ; Bovo-Heijmans B; Diggle J; Fluit AC; Wootton M
    Anaerobe; 2021 Jun; 69():102358. PubMed ID: 33741507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis.
    Indiveri MC; Hirsh DC
    Am J Vet Res; 1985 Oct; 46(10):2207-9. PubMed ID: 4062030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of antimicrobial activity of amoxycillin/clavulanic acid against Bacteroides fragilis group.
    García-Rodriguez JA; Garcia Sanchez JE; Munoz Bellido JL; Trujillano I
    J Chemother; 1989 Jul; 1(4 Suppl):76-7. PubMed ID: 16312311
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
    Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
    J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.
    Lamothe F; Auger F; Lacroix JM
    Antimicrob Agents Chemother; 1984 May; 25(5):662-5. PubMed ID: 6732233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
    Beale AS; Gisby J; Sutherland R
    J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
    Barry AL; Jones RN; Packer RR
    J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
    Pierard D; De Meyer A; Rosseel P; Van Cauwenbergh M; Struelens MJ; Delmee M; Goossens H; Claeys G; Glupczynski Y; Verbist L; Melin P; Lauwers S
    Acta Clin Belg; 1996; 51(2):70-9. PubMed ID: 8693871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM; Seetulsingh P
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.